𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Role of cyclin D1 in ErbB2-positive breast cancer and tamoxifen resistance

✍ Scribed by Marie Ahnström; Bo Nordenskjöld; Lars Erik Rutqvist; Lambert Skoog; Olle Stål

Publisher
Springer US
Year
2005
Tongue
English
Weight
804 KB
Volume
91
Category
Article
ISSN
0167-6806

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Downregulation of erbB3 abrogates erbB2-
Downregulation of erbB3 abrogates erbB2-mediated tamoxifen resistance in breast cancer cells
✍ Bolin Liu; Dalia Ordonez-Ercan; Zeying Fan; Susan M. Edgerton; XiaoHe Yang; Ann 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 654 KB

## Abstract Receptor tyrosine kinase activity is essential for erbB2 (HER2/__neu__) promotion of breast carcinogenesis, metastasis and therapeutic resistance. erbB2 kinase can be activated by dimerization with another erbB receptor, most of which bind ligands. Of these, the erbB2/erbB3 heterodimer

Location, location, location: The role o
Location, location, location: The role of cyclin D1 nuclear localization in cancer
✍ Andrew B. Gladden; J. Alan Diehl 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB

## Abstract The control of cell proliferation is crucial in maintaining cellular homeostasis and loss of this mechanism is a principle hallmark of cancer cells. A primary target of growth factor signaling is the cyclin D1‐dependent kinase (D1‐CDK4/6) whose activity promotes G~1~ phase progression b